Respiratory arrest in a child after flushing of pancuronium from the dead space of intravenous cannula by Khan, R. I. et al.
eCommons@AKU
Department of Anaesthesia Medical College, Pakistan
January 2002
Respiratory arrest in a child after flushing of
pancuronium from the dead space of intravenous
cannula
R. I. Khan
Aga Khan University
Fazal Hameed Khan
Aga Khan University, fazal.hkhan@aku.edu
H .I Naqvi
Aga Khan University
Follow this and additional works at: http://ecommons.aku.edu/pakistan_fhs_mc_anaesth
Part of the Anesthesiology Commons
Recommended Citation
Khan, R., Khan, F., Naqvi, H. (2002). Respiratory arrest in a child after flushing of pancuronium from the dead space of intravenous
cannula. Journal of Pakistan Medical Association, 52(10), 487-488.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_anaesth/96
Respiratory Arrest in a Child after Flushing of Pancuronium
from the Deadspace of Intravenous Cannula
R. I. Khan,F. H. Khan,H .1. Naqvi ( Department of Anaesthesiology, The Aga Khan University
Hospital, Karachi. ) 
Introduction 
It is common practice for patients admitted to Intensive Care Units to have indwelling intravenous
cannulae. Sometimes these cannulae are used only for the administration of drugs and are closed
otherwise. Residual drugs in the deadspace of these intravenous cannulae as well as connected stoppers
or 3-way stopcocks can later be flushed unknowingly. We would like to report a case in which
inadvertent flushing of residual pancuronium caused complete muscle paralysis and respiratory arrest
in a young child.
Case Report 
A 5-month-old female child weighing 4.45 kg was admitted to Intensive Care Unit of our hospital for
hypocalcemic seizures that lead to cardiorespiratory arrest. Her trachea was intubated and mechanical
ventilation started. After detailed investigations, the final diagnosis of rickets was made. During the
course of her ICU stay she developed acute respiratory distress syndrome (ARDS) and abdominal
distention. It was difficult to ventilate her with assisted modes of ventilation so controlled ventilation
was instituted using pancuronium for muscle relaxation which was administered in hourly boluses. She
was treated medically for her problems and on 17th day of intubation, she was finally extubated. She
remained well and active for 2 hours post extubation. Arterial blood gases done at that time showed a
pH of 7.38, PCO2 38 mm Hg, P02 98 mm Hg, H2C03 23 meq/L and Sp02 98% on Fi02 of 40% via
oxyhood. During that period she had two 24 G x3/4 11 cannulae in each arm. The cannula on the left
arm was being flushed with continuous intravenous solution, while that on the right arm had a 3 way
stopcock (Nipro medical industries limited, Japan) attached to it and was closed with a heplock stopper.
Two hours after extubation a nurse flushed the cannula on right arm with saline to keep it patent. The
child immediately desaturated, became bradycardiac and developed complete flaccid paralysis.
Intravenous atropine was given, child’s trachea intubated and bagging with 100% oxygen started.
Cardiac rhythm reverted back to normal within 1-2 minutes. Due to the presence of sudden flaccid
paralysis without any obvious reason, inadvertent administration of muscle relaxant was suspected. A
nerve stimulator demonstrated complete neuromuscular paralysis. She was connected to the ventilator
to facilitate positive pressure ventilation. Neuromuscular function checked at regular intervals showed
a typical pattern of gradual reversal from the effects of a non-depolarizing muscle relaxant. The patient
regained full muscle power after about one hour and was uneventfully extubated the next morning and
later moved to the ward. Detailed inquiry revealed that the last drug given through the right arm
cannula via 3 way stopcock prior to flushing with saline was 0.5 mg of pancuronium diluted in 1 ml of
water injected 6 hours ago. It was concluded that some residual drug remained in the 3-way stopcock
and cannula which was later flushed into circulation resulting in apnea of the child.
Discussion 
Increasing awareness about the transmission of diseases through the needlestick injuries or cuts and
abrasions on the skin has initiated the physicians today to use cannulae with attached injection ports or
heplocks and 3-way stopcocks. However they have their own drawbacks. The volume of drug retained
in the equipment deadspace may result in delivery of an inadequate dose of the drug to the patient. In
addition, subsequent flushing of these relatively smaller drug volumes has been shown to have
surprisingly active clinical effects1.
It is a known fact that between 10 to 30% of 1 ml of intravenous injection may remain in the deadspace
of a cannula or indwelling needle depending on the type and gauge of the equipment used2. The
recommended method of calculating the deadspace of intravenous equipment is to weigh it before and
after filling it with water2 or normal saline1 . Substraction of dry weight from the wet weight is equal to
the deadspace. Weight is converted to volume by assuming 1 gm of 0.9 % normal saline at room
temperature is equal to 0.995 ml while I gm of sterile water is equal to 1 ml. In order to calculate the
combined deadspace of cannula and 3-way stopcock we used the method described by Maclie and
filled the deadspace of the equipment with sterile water. 10 cannulae (Safelet Cath, Nipro Medical
Industries limited, Japan) of 24 G x3/4” were taken and separately connected to 10 3-way stopcocks
(Nipro Medical Industries Limited, Japan). This equipment was the same as used in the clinical setting.
A scale was zeroed after placing a beaker over it. Dry weight of every device was measured
individually. Wet weight was calculated by filling the apparatus with sterile water. Every possible
precaution was taken to remove air bubbles and the exterior of the device was carefully dried before
weighing. To simulate the clinical setting, filling was carried out using 5 ml BD syringe like the one
used in ICU to inject pancuronium. The syringe was removed before measurements. The difference of
two weights in each device was taken as equivalent to the deadspace which was then converted to
volume. Mean deadspace came out to be 0.20 ml. In our ICU, the routine is to dilute the hourly dose of
a drug in 1 ml of water. In the present instance 0.5 mg of pancuronium was diluted in 1 ml of water.
0.20 ml of equipment deadspace contained 0.1 mg of the drug, which in a 4.45 kg weight child was
0.022 mg/kg. Although less than the recommended paralysing dose, it was still found sufficient to
paralyze her when flushed into the circulation. Several authors have reported that low doses of muscle
relaxants can cause distressing symptoms. D-tubocurarine 0.05 mg/kg3, pancuronium 0.014 mg/kg4,
atracurium 0.025 mg/kg5 , vecuronium 0.005-0.0 10 mg/kg6 and suxamethonium 0.07 mg/kg7 can
cause distressing symptoms such as ptosis, blurring of vision, and difficulty in breathing in a large
proportion of patients, with a measurable degree of respiratory impairment in a significant number of
them. This effect may become more pronounced in a partially reversed patient or in patients who have
reduced respiratory reserve.
Similar cases of muscle paralysis have been reported postoperatively in children8 as well as in adults9
after flushing of cannulae through which suxamethonium had previously been injected but to our
knowledge, no case has been reported of a similar event in the setting of intensive care unit or where
pancuronium has been used. Physicians working in intensive care units should keep this possibility in
mind so that they can intervene early and prevent any fatal complications. We recommend that if 3-way
stopcocks or heplock stoppers are being used for administration of drugs in pediatric patients in
intensive care units, they should be flushed immediately afterwards with saline or water. We also
suggest that all unnecessary intravenous lines should be removed whenever possible.
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